Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

<p>Abstract</p> <p>Background</p> <p>Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic synd...

Full description

Bibliographic Details
Main Authors: Scott Russell, Donoghoe Mark, Watts Gerald F, O'Brien Richard, Pardy Christopher, Taskinen Marja-Riitta, Davis Timothy ME, Colman Peter G, Manning Patrick, Fulcher Gregory, Keech Anthony C
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/10/1/102

Internet

http://www.cardiab.com/content/10/1/102

Similar Items